insights_auto
Sebab ALNY menurun 4.54%?
Terokai Dengan Lebih Terperincichevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
USD 149.40
arrow_downward
-4.54%(-7.10) 1H
USD 149.95
arrow_upward
+0.37% (+0.55)bedtimeSelepas waktu pejabat
Ditutup: 18 Nov, 4:00:01 PTG GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk ALNY...
Buka
USD 155.00
Tinggi
USD 157.28
Rendah
USD 147.58
Permodalan Pasaran
20.01B
Purata volum
2.65J
Volum
2.52J
Nisbah H/P
7.57
tgi 52 mgu
USD 479.79
rdh 52 mgu
USD 147.58
EPS
USD 19.75
Beta
0.42
Syer tertunggak
133.94J
Bilangan pekerja
2K
Buka
USD 155.00
Tinggi
USD 157.28
Rendah
USD 147.58
Permodalan Pasaran
20.01B
Purata volum
2.65J
Volum
2.52J
Nisbah H/P
7.57
tgi 52 mgu
USD 479.79
rdh 52 mgu
USD 147.58
EPS
USD 19.75
Beta
0.42
Syer tertunggak
133.94J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Investing.com
·
5 jam lalu
Alnylam Pharmaceuticals stock hits 52-week low at 149.17 USD
Investing.com
·
11 jam lalu
JPMorgan cuts Alnylam stock price target on Amvuttra forecast
TradingView
·
13 jam lalu
ALNY: AMVUTTRA adoption and 2027 access shifts shape near-term priorities; TRITON-CM targets ~2030
Investing.com
·
14 jam lalu
Alnylam at Jefferies Global Healthcare Conference: growth meets payer pressure
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Perihal Alnylam Pharmaceuticals, Inc.